Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publikationen/407-phase-ii-study-of-sunitinib-administered-in-a-continuous-once-daily-dosing-regimen-in-patients-with-cytokine-refractory-metastatic-renal-cell-carcinoma/autoren